Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
- PMID: 33875563
- PMCID: PMC8057070
- DOI: 10.1136/openhrt-2021-001655
Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
Keywords: COVID-19; cardiomyopathy; electronic health records; hypertrophic.
Conflict of interest statement
Competing interests: JJD is director of scientific affairs for advanced ingredients for dietary products. MM owns a nutraceutical company.
Comment on
-
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19.Open Heart. 2020 Sep;7(2):e001350. doi: 10.1136/openhrt-2020-001350. Open Heart. 2020. PMID: 32895293 Free PMC article. No abstract available.
References
-
- Covid Analysis . Ivermectin is effective for COVID-19: real-time meta analysis of 44 studies, 2021.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical